Embed

Academic

Authors

Jacqueline Murray

Jacqueline Murray,University of Washington,Cell Biology,Biochemistry,Medicine

Edit

Jacqueline Murray

University of Washington

Publications: 23 | Citations: 251

Fields: Cell Biology, Biochemistry, Medicine

Collaborated with 50 co-authors from 1956 to 2011 | Cited by 1104 authors

Cumulative Annual

Sort by:

Publications (23)

BibTeX | RIS | RefWorks Download

Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis

, , , , , , , ,

Journal: Atherosclerosis , vol. 216, no. 2, pp. 292-298, 2011

Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity (Citations: 1)

, , , , , , , , , ,

Journal: Journal of Cellular Biochemistry - J CELL BIOCHEM , 2010

Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells (Citations: 21)

, , , , , ,

Journal: BMC Cell Biology - BMC CELL BIOL , vol. 6, no. 1, pp. 8-17, 2005

Fibronectin promotes VEGF-induced CD34 + cell differentiation into endothelial cells (Citations: 42)

, , , , ,

Journal: Journal of Vascular Surgery - J VASC SURG , vol. 39, no. 3, pp. 655-660, 2004

Expression of vascular endothelial growth factor receptors in smooth muscle cells (Citations: 95)

, , , , , ,

Journal: Journal of Cellular Physiology - J CELL PHYSIOL , vol. 188, no. 3, pp. 359-368, 2001

Sort by:

Citations (251 times by 225 publications)

The Related Transcriptional Enhancer Factor1 Isoform, TEAD4216, Can Repress Vascular Endothelial Growth Factor Expression in Mammalian Cells

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57405617&selfId1=23659212&selfId2=0&maxNumber=12&query=

Journal: PLOS One , vol. 7, no. 6, 2012

Factor Xa Induces Tissue Factor Expression in Endothelial Cells by P44/42 MAPK and NF-κB-Dependent Pathways (Citations: 1)

, , , , , ,

Journal: Journal of Surgical Research - J SURG RES , vol. 169, no. 2, pp. 319-327, 2011

Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ (Citations: 1)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=47614115&selfId1=23659212&selfId2=0&maxNumber=12&query=

Journal: Basic Research in Cardiology - BASIC RES CARDIOL , vol. 106, no. 2, pp. 217-231, 2011

Fibronectin Growth Factor-Binding Domains Are Required for Fibroblast Survival

, , , , , , , ,

Published in 2011.

RISK STRATIFICATION AND EARLY INVASIVE STRATEGY IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST ELEVATION. MEDICAL JUDGMENT AND TIMI RISK SCORE IN THE REAL WORLD

Journal: Journal of The American College of Cardiology - J AMER COLL CARDIOL , vol. 57, no. 14, pp. E1066-E1066, 2011

Comments

Co-authors (50)

Journals (6)

Keywords (68)

Jacqueline Murray,University of Washington,Cell Biology,Biochemistry,Medicine

Publications (23)

BibTeX | RIS | RefWorks Download

Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis

Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity (Citations: 1)

Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells (Citations: 21)

Fibronectin promotes VEGF-induced CD34 + cell differentiation into endothelial cells (Citations: 42)

Expression of vascular endothelial growth factor receptors in smooth muscle cells (Citations: 95)

Citations (251 times by 225 publications)

The Related Transcriptional Enhancer Factor1 Isoform, TEAD4216, Can Repress Vascular Endothelial Growth Factor Expression in Mammalian Cells

Factor Xa Induces Tissue Factor Expression in Endothelial Cells by P44/42 MAPK and NF-κB-Dependent Pathways (Citations: 1)

Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ (Citations: 1)

Fibronectin Growth Factor-Binding Domains Are Required for Fibroblast Survival

RISK STRATIFICATION AND EARLY INVASIVE STRATEGY IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST ELEVATION. MEDICAL JUDGMENT AND TIMI RISK SCORE IN THE REAL WORLD


	View FAQ about top research areas and Fields of study

Jacqueline Murray,University of Washington,Cell Biology,Biochemistry,Medicine

Publications (23) BibTeX | RIS | RefWorks Download

Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity (Citations: 1)

Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells (Citations: 21)

Fibronectin promotes VEGF-induced CD34 + cell differentiation into endothelial cells (Citations: 42)

Expression of vascular endothelial growth factor receptors in smooth muscle cells (Citations: 95)

Factor Xa Induces Tissue Factor Expression in Endothelial Cells by P44/42 MAPK and NF-κB-Dependent Pathways (Citations: 1)

Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ (Citations: 1)

Publications (23)

BibTeX | RIS | RefWorks Download